SPOTLIGHT -
Alameda, CA-InSite Vision Inc. and Bausch & Lomb have signed a licensing agree-ment to develop InSite's product ISV-403 for the treatment of ocular bacterial infections.
The ins and outs of treating ‘financial cataracts’
Planning for financial safety in uncertain times
Are there alternative opportunities in volatile markets?
The sword and shield of investing
Ten steps for planning your retirement cash flow
Webinar replay: Channeling the Beatles in a financial market outlook – come together